PALOMAR MEDICAL TECHNOLOGIES INC: 10-Q filed 2011-08-09
What PALOMAR MEDICAL TECHNOLOGIES INC reported in its quarterly report filed 2011-08-09 (fiscal Q2 2011): 37 published measures, 100 facts as tagged in accession 0000881695-11-000027.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-08-09
- Fiscal period
- fiscal Q2 2011
- Accession
- 0000881695-11-000027 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALOMAR MEDICAL TECHNOLOGIES INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 156,463,823 | USD | |
| At 2010-12-31 | 159,577,503 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 20,760,541 | USD | |
| At 2010-12-31 | 20,283,835 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 135,703,282 | USD | |
| At 2010-12-31 | 139,293,668 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 65,515,954 | USD | |
| At 2010-12-31 | 55,099,319 | USD | |
| At 2010-06-30 | 102,119,967 | USD | |
| At 2009-12-31 | 81,948,482 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -3,998,921 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -5,892,913 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -1,695,054 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -4,199,093 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -10,962,184 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -3,130,730 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 702,941 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 3,220,383 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 16,265,245 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 34,420,975 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 15,590,159 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 31,590,513 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 187,132 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 48,708 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 21,109,379 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 23,329,617 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -77,674,076 | USD | |
| At 2010-12-31 | -71,781,163 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 18,699,608 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 18,688,202 | shares | 181 |
| 2010-04-01 to 2010-06-30 | 18,536,076 | shares | 91 |
| 2010-01-01 to 2010-06-30 | 18,528,650 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 18,699,608 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 18,688,202 | shares | 181 |
| 2010-04-01 to 2010-06-30 | 18,536,076 | shares | 91 |
| 2010-01-01 to 2010-06-30 | 18,528,650 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -0.21 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | -0.32 | USD/shares | 181 |
| 2010-04-01 to 2010-06-30 | -0.09 | USD/shares | 91 |
| 2010-01-01 to 2010-06-30 | -0.23 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -0.21 | USD/shares | 91 |
| 2011-01-01 to 2011-06-30 | -0.32 | USD/shares | 181 |
| 2010-04-01 to 2010-06-30 | -0.09 | USD/shares | 91 |
| 2010-01-01 to 2010-06-30 | -0.23 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 56,473 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 95,726 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 28,868 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 48,002 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 37,166,669 | USD | |
| At 2010-12-31 | 37,165,306 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 2,133,477 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 1,912,697 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -4,060,615 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -6,038,577 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -1,565,598 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -4,174,346 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 105,482,532 | USD | |
| At 2010-12-31 | 108,342,446 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 17,865,755 | USD | |
| At 2010-12-31 | 17,429,758 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 3,351,579 | USD | |
| At 2010-12-31 | 2,293,096 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 7,324,122 | USD | |
| At 2010-12-31 | 5,349,835 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 18,836,613 | USD | |
| At 2010-12-31 | 13,021,272 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 3,880,308 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 7,528,224 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 3,589,269 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 7,775,069 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 19,030,503 | shares | |
| At 2010-12-31 | 18,925,549 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 213,695,941 | USD | |
| At 2010-12-31 | 211,376,381 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -508,888 | USD | |
| At 2010-12-31 | -490,806 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 248,758 | USD | |
| At 2010-12-31 | 219,554 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 8,712,979 | USD | |
| At 2010-12-31 | 10,742,581 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -4,029,702 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -5,910,995 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -1,521,554 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -4,250,158 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 3,782,204 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 7,267,605 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 3,360,348 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 7,312,031 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 702,491 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 634,525 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 29,476 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 39,318 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -191,454 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -184,662 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -1,973,267 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 457,784 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -5,765,014 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -404,911 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 960,346 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 130,697 | USD | 181 |
Inspect the source
- Entity
- PALOMAR MEDICAL TECHNOLOGIES INC / CIK 0000881695
- Captured
- SEC response SHA-256
2dd119a4e9049cd3bb87f5900c35e4922ace75e6dcbfef751515742520a8f1cf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000881695.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))